Citations

Clear

2504 citation(s) found for "Wu, Benjamin".

Ustekinumab for ileal stricturing Crohn’s disease—an international multicenter retrospective cohort study
Ouali, Sara El , Baker, Mark E, Lu, Cathy , Medellin, A, Bruining, David H, Fletcher, Joel G. , Inoue, Aki, Regueiro, Miguel, Ottichilo, Ronald K. , Schoenoff, Shayla, Rosentreter, Ryan E., Qazi, Taha , Holubar, S. D., Gauriloff, Samantha, Gandhi, Namita , Cohen, Benjamin L, Balci, Numan, Rieder, Florian, Regueiro, Miguel , Lu, Cathy , El Ouali, Sara , Regueiro, Miguel , Qazi, Taha , Sleiman, Joseph , Holubar, Stefan D , Rieder, Florian , Fletcher, Joel G , Baker, Mark E. , Medellin, Alexandra , Bruining, David H. , Inoue, Aki, Bena, Jim , Sleiman, Joseph , Holubar, Stefan D. , Cohen, Benjamin L, Goren, Idan , Rieder, Florian

Mayo Clinic

Journal of Crohn's and Colitis | March 23, 2026 | Volume: 20 | Issue: 3 | Pages: No page available

10.1093/ecco-jcc/jjag038 | PMID 41934342 Get It

Abstract Background & Aims Stricturing Crohn’s disease (CD) is a significant problem, and no selective anti-fibrotic therapies are available. Anti-inflammatory approaches are the mainstay of medical treatment. However, data on the efficacy of ustekinumab (USTE) in ileal stricturing CD are lacking. Our aim was to assess its efficacy in this setting. Methods We performed an international multicenter observational cohort study evaluating adult CD patients who received USTE within 6 months of imaging-confirmed symptomatic stricturing small bowel disease. Outcomes were rates of endoscopic balloon dilation (EBD), surgery, intervention (defined as the composite need for EBD or surgery), recurrent obstructive symptoms, and USTE persistence. Results Fifty-seven patients were included (51% female, median age 43 years). Median follow-up was 17 months. Intervention rates were 35%, 45%, and 69% of patients, at 12, 24, and 48 months, respectively. USTE persistence was 78%, 76%, and 52% at 12, 24, and 48 months. Estimated obstructive symptoms rates were 31% and 49% at 12 and 24 months, respectively. EBD within 6 months prior to starting USTE was associated with an increased risk of intervention. Increased bowel wall thickness on imaging, prior biologic use, and obstructive symptom duration were associated with USTE discontinuation. Occurrence of obstructive symptoms during treatment was associated with prior biologic use, EBD within 6 months of starting USTE, and a lower BMI. Conclusions USTE appears to be an appropriate medical option in biologic-experienced CD patients with ileal strictures. Further prospective data are needed to better define outcomes and predictors of response in this setting.
VarStack2—an interactive web tool for somatic variant interpretation in cancer
Sreekumar, Nitin, Ahn, Benjamin J, Tian, Shulan , Uzun, Alper , Uzun, Ece D. Gamsiz , Gamsiz Uzun, Ece D

Mayo Clinic

Database | March 21, 2026 | Volume: 2026 | Issue: No issue available | Pages: No page available

10.1093/database/baag016 | PMID 41968112 Get It

Abstract The rapid progress in tumour genome sequencing has created a need for bioinformatics tools to interpret the clinical significance of detected variants. VarStack² integrates information from several publicly available resources, including the Catalogue of Somatic Mutations in Cancer (COSMIC), ClinVar, cBioPortal, UCSC Genome Browser, and ClinicalTrials.gov, CIViC and presents it through a user-friendly interface. VarStack2 simplifies the process of retrieving data, saving users significant time compared to manually navigating each database individually. Users can input a variant by specifying a gene symbol, amino acid change, and coding sequence change, with the option to search tumour-specific studies in cBioPortal alongside their primary query. Results are organized into separate sections and can be exported in CSV format for further analysis. Additionally, VarStack2 offers a smart search feature that suggests variants for the gene of interest based on its database search results. These features make VarStack2 a useful tool for scientists and clinicians by enhancing the variant interpretation process and integrating somatic variant information into workflows. VarStack² is freely available at http://varstack.brown.edu/
Refining BCG ‐failure classifications in non‐muscle‐invasive bladder cancer
Ślusarczyk, Aleksander , Contieri, Roberto, Krajewski, Wojciech, Claps, Francesco, Subiela, José Daniel, Mertens, Laura S., Mori, Keiichiro, Grobet‐Jeandin, Elisabeth, Velasco, J. Caño, Tully, Karl H., Soria, Francesco, Duran, P. Del Olmo, Puentedura, A. Lafuente, Lijnen, Renee A.G. , Longoni, Mattia, Marcq, Gautier, Mari, Andrea, Laukhtina, Ekaterina, Afferi, Luca, Albisinni, Simone, Gallioli, Andrea, Giudice, Francesco Del, Boorjian, Stephen A., Briganti, Alberto, Shariat, Shahrokh F., Gontero, Paolo, Radziszewski, P., Moschini, Marco, Pradere, Benjamin, group, Urothelial carcinoma working, Mertens, Laura S. , Contieri, Roberto , Claps, Francesco , Subiela, José Daniel , Mertens, Laura S , Mori, Keiichiro , Tully, Karl H , Soria, Francesco , Mari, Andrea , Laukhtina, Ekaterina , Afferi, Luca , Albisinni, Simone , Gallioli, Andrea , Del Giudice, Francesco , Moschini, Marco , Scilipoti, Pietro , Krajewski, Wojciech R. , Mori, Keiichiro , Grobet-Jeandin, Élisabeth , Tully, Karl H. , Longoni, Mattia , Marcq, Gautier , Laukhtina, Ekaterina , Albisinni, Simone , Boorjian, Stephen A. , Briganti, Alberto, Shariat, Shahrokh F. , Gontero, Paolo , Moschini, Marco , Pradère, Benjamin

Mayo Clinic

BJU International | March 20, 2026 | Volume: 137 | Issue: 6 | Pages: 1076-1087

10.1111/bju.70231 | PMID 41858138 Get It

Objective To validate International Bladder Cancer Group (IBCG) definitions of Bacillus Calmette‐Guérin (BCG)‐unresponsive and BCG‐exposed non‐muscle‐invasive bladder cancer (NMIBC) and assess prognostic heterogeneity across various BCG‐failure types. Patients and Methods From a multicentre international cohort of 3806 BCG‐treated patients, 591 who developed high‐grade NMIBC recurrence following BCG between 2003 and 2024 were included. Progression‐free survival (PFS) was the primary endpoint; cancer‐specific (CSM) and overall mortality (OM) were secondary endpoints. Cumulative incidence functions, competing‐risk models and multivariable Cox regression were used. Results Patients with BCG‐unresponsive and BCG‐exposed disease showed similar PFS, CSM, and OM (all P > 0.05). When stratified into five subgroups, prognosis varied: 5‐year progression rates were 29% for BCG‐unresponsive, 32.5% for late relapse (between 6 and 24 months) after adequate BCG, 30% for BCG‐exposed with inadequate BCG (<24 months from induction), 6.2% for BCG‐resistant, and 14% for very late relapse (>24 months since last BCG) ( P < 0.01). In multivariable analysis, BCG‐exposed after inadequate BCG (subdistribution hazard ratio [sHR] 3.42, 95% confidence interval [CI] 1.33–8.84), late relapse (sHR 3.74, 95% CI 1.59–8.78), and BCG‐unresponsive (sHR 2.34, 95% CI 1.00–5.44) were associated with higher progression risks compared to very late relapse. Limitations include retrospective design and treatment heterogeneity. Conclusions Under IBCG definitions, BCG‐unresponsive and BCG‐exposed NMIBC have similarly poor outcomes. A refined classification reveals prognostic heterogeneity, with late relapses after adequate BCG demonstrating outcomes comparable to BCG‐unresponsive, and very late relapses conferring better prognosis.
Bertolotti joint–related cyst: illustrative case
Chow, W , Spinner, Robert J., Amrami, Kimberly K., Elder, Benjamin D. , Steinmetz, Michael P., Chow, William D, Spinner, Robert J , Chow, William D., Spinner, Robert J. , Amrami, Kimberly K. , Steinmetz, Michael P.

Mayo Clinic

Journal of Neurosurgery: Case Lessons | March 19, 2026 | Volume: 11 | Issue: 11 | Pages: No page available

10.3171/case25948 | PMID 41871426 Get It

BACKGROUND Bertolotti syndrome is an underrecognized cause of chronic low back pain. Back pain generated from Bertolotti syndrome is believed to result from altered weight dissipation mechanics and/or instability of the pseudoarticulation, while local nerve root compression may result in radiculopathy. Here, the authors describe the findings of a patient with treatment-refractory low back pain found to have a cystic lesion arising from a Bertolotti joint causing L5 nerve root compression. To their knowledge, this has not been previously described in the literature. OBSERVATIONS Despite early recognition of Bertolotti syndrome, the patient’s back pain remained resistant to many years of both conservative and surgical management. The novel finding of a cyst arising from the pseudoarticulation complicated the management. The patient is scheduled to undergo further surgery this year. LESSONS This case highlights a pseudocyst associated with a Bertolotti joint. The cyst introduced additional clinical uncertainty to what is already an uncommon and difficult to treat condition. Resection of the Bertolotti joint failed to improve the patient’s symptoms. Postoperatively, a complex hemorrhagic pseudocyst was seen on imaging, possibly due to the pseudoarticulation with persistent motion. Ongoing efforts to characterize Bertolotti syndrome and its associated imaging findings are necessary to better optimize management strategies in these patients. https://thejns.org/doi/10.3171/CASE25948
Retrocecal Appendicitis in Children
Ashby, Ben, Bellolio, Fernanda, Klinkner, Denise B. , Penfold, Mike, Ashby, Benjamin, Mullan, Aidan F. , Jeffery, Molly Moore , Anderson, Jana L.

Mayo Clinic

Pediatric Emergency Care | March 19, 2026 | Volume: 42 | Issue: 7 | Pages: 551-555

10.1097/pec.0000000000003590 | PMID 41854115 Get It

Purpose: The anatomic position of the appendix may influence both the clinical presentation and diagnostic imaging accuracy in pediatric appendicitis, but its impact remains uncertain. This study aimed to determine the prevalence of retrocecal appendicitis in children and to evaluate whether appendix positioning affects ultrasound diagnostic performance or clinical outcomes. Methods: This was a retrospective cohort study including all children 0 to 18 years of age who presented to the Mayo Clinic Rochester Emergency Department between 2018 and 2023 and were diagnosed with appendicitis during their evaluation or subsequent hospitalization. Appendix location was determined by imaging or surgical documentation. Demographics, symptoms, signs, and complication rates were collected for patients with retrocecal appendicitis (RCA) and non-retrocecal appendicitis (NRCA). Results: Four hundred seven patients were included with 12.5% having RCA. Ultrasound was obtained in 92% of patients with RCA versus 82% of NRCA (rate difference: 10%, 95% CI: 2%-19%, P =0.018). In patients who received ultrasound imaging, findings were equivocal or falsely negative in 53% of RCA patients versus 30% of NRCA patients (RD = 24%, 9%-39%; P =0.003). Computed tomography (CT) was obtained in 51% of RCA patients versus 29% of NRCA (RD = 22%, 8%-37%; P =0.003) and was equivocal or falsely negative at similar rates in RCA (12%) and NRCA (13%; P =0.88). Clinically, there were no differences in diarrhea, emesis, location of abdominal pain, or white blood cell counts between RCA and NRCA. Rates of perforation, abscess formation, hospitalization longer than 7 days, and repeat hospitalizations were also similar. Conclusions: Retrocecal appendicitis is a common anatomic variant in children that presents with similar clinical features and outcomes compared with non-retrocecal appendicitis. However, its retrocecal position reduces the diagnostic sensitivity of limited abdominal ultrasound, often necessitating additional imaging with computed tomography. Despite these diagnostic challenges, retrocecal positioning is not associated with a worsened clinical course.
Sex differences in neuromodulatory subcortical systems and their implications for Alzheimer's disease
Rae, Rosaria J., Alberhasky, Jessica Marie Hunter, Bangasser, Debra A. , Berteotti, Chiara, Bow, Hannah, Caldwell, Jessica Z. K., Carpi, Matteo , Ciampa, Claire J., Ehrenberg, Alexander J. , Fenlon, Haley A., Fitzhugh, Megan C. , Gallay, Clara , Hamilton, Derek A. , Hasan, Zia , Huarte, Oihane Uriarte , Jabeen, Shaista , Kolling, Louis John , Liguori, Claudio , Omoluabi, Tamunotonye, Pa, Judy, Pentkowski, Nathan S. , Pereira, Joana B., Ramos, Rhudovic R., Sargin, Derya , Seto, Mabel, Shaik, Shabana M. , Ucheagwu, Valentine , Kelberman, Michael A. , Grinberg, Lea Tenenholz, Satpati, Abhijit, Son, Gowoon, Rae, Rosaria Josephine, Baillet, Marion , Belloy, Michaël E. , Berry, Anne S. , Berteotti, Chiara , Bow, Hannah, Buckley, Rachel F. , Caldwell, Jessica K. , Clark, Benjamin J. , Conley, Alexander C. , Dahl, Martin J. , Donaldson, Zoe R. , Einstein, Gillian , Falgàs, Neus , Froemke, Robert C. , Grinberg, Lea T. , Jacobs, Heidi I.L. , Koops, Elouise A. , Lenzoni, Sabrina , Manca, Riccardo , Marcinkiewcz, Catherine Anne , Omoluabi, Tamunotonye, Oria, Rademene Sunday , Orsini, Caitlin A. , Ortega, Nancy Elizabeth , Pa, Judy , Pereira, Joana B. , Satpati, Abhijit , Sellés, María Clara , Seto, Mabel , Sindi, Shireen , Son, Gowoon , Egroo, Maxime Van , Yuan, Qi

Mayo Clinic

Alzheimer's & Dementia | March 19, 2026 | Volume: 22 | Issue: 3 | Pages: No page available

10.1002/alz.71291 | PMID 41853971 Get It

Abstract Neuromodulatory subcortical systems (NSSs) are uniquely susceptible to dementia‐related pathology, leading to frequent molecular and behavioral impairments associated with altered function of these nuclei. Some of these systems display clear sex‐specific cytoarchitecture and signaling leading to distinct physiology and behavioral outputs in males and females, while other regions display nominal sex differences. However, the relevance of sex differences in modulating dysfunction of NSSs in Alzheimer's disease (AD) and related dementias is not well understood. This review is a joint effort by the Neuromodulatory Subcortical Systems and Sex and Gender Differences in Alzheimer's Disease Professional Interest Areas of the Alzheimer's Association. We review sex differences in NSSs, both in non‐disease states and in AD models and patients. We highlight the possible role of NSSs in driving sex‐specific AD susceptibility and potential footholds for sex‐based interventions targeting these systems. We conclude by outlining immediate and long‐term actions to address the intersection of NSSs, sex, and AD.
Woven EndoBridge Device for Ruptured vs. Unruptured Aneurysms: Insights from the WorldWideWEB Study
Dugar, Franja, Essibayi, Muhammed Amir, Adeeb, N, Algin, Oktay, Ghozy, Sherief, Guenego, Adrien, Renieri, Leonardo, Saliou, G, Shotar, Eimad, Möhlenbruch, Markus, Kral, Michael , Chung, Charlotte, Salem, Mohamed M , Cancelliere, Nicole M., Diestro, Jose Danilo Bengzon, Foreman, Paul M. , Shaikh, Hamza, Župančić, Vedran , Waqas, M, Ayberk, Gıyas , Rabinov, James D. , Maingard, Julian , Schirmer, Clemens M., Piano, M, Michelozzi, Caterina , Starke, Robert M., Hassan, A. E., Ogilvie, Mark, Jones, Jesse, Brinjikji, Waleed , Psychogios, Marios, Nawka, Marie Teresa , Fiehler, Jens, Nguyen-Kim, Thi Dan Linh, Pukenas, Bryan , Burkhardt, J. David, Huynh, Thien, Martinez-Gutierrez, Juan Carlos, Sheth, S, Slawski, Diana , Lubicz, Boris , Puri, A, Raz, E, Griessenauer, Christoph J., Asadi, Hamed, Siddiqui, Adnan, Levy, Elad I, Haranhalli, Neil , Altschul, David, Ducruet, Andrew F. , Regenhardt, Robert W., Stapleton, Christopher J. , Kan, Peter , Lylyk, Pedro, Boddu, Srikanth, Knopman, Jared, Tjoumakaris, Stavropoula I., Cuellar-Saenz, Hugo H., Jabbour, Pascal M., Clarençon, Frédéric, Patankar, Tufail , Pereira, Vitor Mendes, Patel, Aman B., Almohammad, Mohammad, Kemmling, Andre, Dmytriw, Adam A., Diestro, Jose Danilo Bengzon , Diestro, Jose Danilo B , Dugar, Franja , Essibayi, Muhammed Amir , Salim, Hamza , Musmar, Basel , Adeeb, Nimer , Dibas, Mahmoud , Li, Yan-Lin, Algin, Oktay , Ghozy, Sherief , Lay, Sovann V. , Guenego, Adrien , Renieri, Leonardo , Carnevale, Joseph, Saliou, Guillaume , Mastorakos, Panagiotis , Shotar, Eimad , Möhlenbruch, Markus , Salem, Mohamed Raafet Ben, Lylyk, Iván , Cancelliere, Nicole M , Hafeez, Muhammad Ubaid , Catapano, Joshua S , Waqas, Muhammad , Ayberk, Gıyas , Arslan, Muhammet , Ergun, Onur, Maingard, Julian, Schirmer, Clemens M. , Piano, Mariangela , Kühn, Anna L., Starke, Robert M., Hassan, Ameer, Ogilvie, Mark , Jones, Jesse , Zaccagna, Fulvio , Grist, James T. , Psychogios, Marios‐Nikos , Fiehler, Jens , Nguyen‐Kim, Thi Dan Linh , Burkhardt, Jan‐Karl , Huynh, Thien , Martinez-Gutierrez, Juan Carlos , Sheth, Sunil A , Tawk, Rabih G. , Pulli, Benjamin , Panni, Pietro , Puri, Ajit S., Pero, Guglielmo , Raz, Eytan , Griessenauer, Christoph J. , Asadi, Hamed , Siddiqui, Adnan H. , Levy, Elad I. , Altschul, David , Regenhardt, Robert W. , Kan, Peter , Kalousek, Vladimir , Lylyk, Pedro, Knopman, Jared , Tjoumakaris, Stavropoula , Cuellar, Hugo , Jabbour, Pascal , Clarençon, Frédéric , Limbucci, Nicola , Patel, Aman B. , Almohammad, Mohammad , Kemmling, André , Scarcia, Luca , Dmytriw, Adam A. , Sporns, Peter Bernhard

Mayo Clinic

No container title available | March 18, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-8939206/v1 Get It

Abstract Purpose Although the Woven EndoBridge (WEB) device is increasingly used for the treatment of wide-neck intracranial aneurysms, including in the acute rupture setting, comparative evidence assessing the impact of rupture status remains limited. This study compared angiographic, safety, and clinical outcomes between ruptured and unruptured intracranial aneurysms treated with WEB. Methods We conducted a retrospective analysis of prospectively collected data from the multicenter cohort registry WorldWideWEB, including consecutive adult patients with intracranial aneurysms treated with the WEB. Patients were stratified into groups of ruptured and unruptured aneurysms. Propensity score matching was used to balance baseline characteristics between both groups. Retreatment rate was the primary outcome. Secondary outcomes included mRS, safety events (thromboembolic complications) and angiographic outcomes (periprocedurally and last follow-up). Results Among 1,220 patients, 342 (28.0%) presented with ruptured aneurysms. There was no significant difference in the rate of thromboembolic complications between groups (11.8% vs 5.9%, p = 0.056). At follow-up, adequate occlusion was lower (82.2% vs 93.3%, p < 0.002) and functional outcomes were worse (mRS ≥2 in 34.1% vs 21.9%, p = 0.012) among patients with ruptured aneurysms. Periprocedural adequate occlusion (53.3% vs 53.8%, p>0.9) and retreatment rates (11.8% vs 7.1%, p = 0.14) did not differ between groups after matching. Conclusion Ruptured aneurysms demonstrated expected inferior follow-up functional and angiographic outcomes when compared with unruptured aneurysms, but no difference in retreatment rate and procedural safety. These findings support WEB as a safe and effective treatment option for appropriately selected ruptured intracranial aneurysms in routine clinical practice.
Maternal obesity induces developmental programming of Intestinal stem cells through an IL-17A/PPAR immune-epithelial axis
Lahiri, Gourab , Millan, Yesenia Barrera, Sankar, Swathi , Mullen, Karla F, McDermott, Thomas Hartley, Saiz, Dominic R. , Farnsworth, Fiona , Torel, Matt , Blatt, Madeline , Roginski, Ana Cristina , Shukla, Abhigyan, Florsheim, Esther Borges , Khazaie, Khashayarsha , Barrera Millan, Yesenia , Sankar, Swathi , Mullen, Karla , Hartley McDermott, Thomas , Florsheim, Esther , Bartelle, Benjamin B , Khazaie, Khashayarsha , Gounari, Fotini , Mana, Miyeko D , Bartelle, Benjamin B. , Gounari, Fotini

Mayo Clinic

No container title available | March 18, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.64898/2026.03.15.711939 | PMID 41889880 Get It

ABSTRACT Maternal obesity is associated with increased risk of sporadic colorectal cancer (CRC) in offspring, suggesting that early-life environmental exposures durably shape disease susceptibility. Intestinal stem cells (ISCs), long-lived drivers of epithelial renewal and tumor initiation, are well poised to mediate this effect; however, how maternal obesity influences ISC programming during development remains poorly understood. Using mouse models of diet-induced obesity, we show that exposure to a maternal high-fat Western diet (mHFD) during pre- and postnatal development stably programs colonic ISCs. Offspring exhibit increased ISC proliferation, enhanced self-renewal, a hypermetabolic state, and altered epithelial lineage composition that persists into adulthood despite dietary normalization. These changes are accompanied by increased tumor burden following loss of Apc heterozygosity. Mechanistically, we identify the pro-inflammatory cytokine IL-17A as a key extrinsic driver and PPARd/a nuclear receptors as intrinsic mediators of the mHFD phenotype, revealing an immune-epithelial axis that programs ISC function during early life. Together, our findings demonstrate that maternal metabolic environments durably enhance stem cell fitness, providing a mechanistic link between developmental exposure and adult disease risk.
Gatherings in Esophagology: Innovations and Future Directions in the Diagnosis and Management of Reflux Disease
Cable, Jennifer, Giuli, R, Fox, Mark , Rosen, Rachel L., Valdovinos‐García, Luis R., Siboni, Stefano, Clarke, John O. , Samuels, Tina L. , Scarpignato, Carmelo , Fass, Ronnie, Remes-Troche, José María, Khan, Abraham, Rahman, Afrin Kamal, Lynch, Kristle L. , Jodorkovsky, Daniela , Vela, Marcelo F. , Vandenberg, Alexandra, Kuo, Braden, Ergün, Pelin , Jirapinyo, Pichamol, Asti, Emanuele, Tolone, Salvatore, Salvador, Renato , Sozzi, Marco, Husain, Inna, Wu, J. , Hobson, Anthony, Sharma, Nirmal , Gyawali, C. Prakash, Sifrim, Daniel, Savarino, E V, Bortoli, Nicola De, Rogers, Benjamin D. , Clarke, J , Valdovinos-García, Luis R. , Siboni, Stefano , Johnston, Nikki , Stein, Ellen M. , Fass, Ronnie , Remes Troche, José M , Kuo, Braden , Jirapinyo, Pichamol , Asti, Emanuele , Sheu, Eric Garland , Sozzi, Marco , Hobson, Anthony, Lo, Wai–Kit , Duncan, Daniel R. , Gyawali, C. Prakash , Chan, Walter W. , Sifrim, Daniel

Mayo Clinic

Annals of the New York Academy of Sciences | March 12, 2026 | Volume: 1557 | Issue: 1 | Pages: No page available

10.1111/nyas.70225 | PMID 41817458 Get It

ABSTRACT Recent advances in the diagnosis and management of reflux disease were the central focus of the inaugural Gatherings in Esophagology (GiE), which convened experts across gastroenterology, surgery, otolaryngology, pulmonology, and basic research. The sessions highlighted innovations in reflux monitoring—including high‐resolution manometry, wireless pH monitoring, and novel salivary biomarkers—while critically evaluating their diagnostic accuracy and clinical utility. Presentations explored the limitations of traditional proton‐pump inhibitor therapy, the emergence of potassium‐competitive acid blockers as a new class of acid suppressants, and the evolving role of adjunctive treatments such as mucosal protectants, reflux reducers, and neuromodulators for refractory symptoms. The discourse extended to advanced interventional procedures, including transoral incisionless fundoplication, magnetic sphincter augmentation, and the RefluxStop device, with discussion of patient selection, efficacy, and complication management. Discussants emphasized the pathophysiology and management of extraesophageal manifestations of reflux, the interplay between reflux and pulmonary disease, and the diagnostic challenges in pediatric populations. The meeting also addressed the integration of behavioral therapies, the role of the microbiome, and the application of artificial intelligence in reflux diagnostics. Collectively, these insights underscore a shift toward precision medicine in reflux disease, emphasizing individualized diagnostic strategies and tailored therapeutic approaches to improve patient outcomes.
Defining Quality Metrics for Telemedicine in Surgery: A Critical Examination
Shao, Connie , Brooke, Benjamin S, Wisbach, Gordon , Sawyer, Mark D. , Redan, Jay, Adelson, P David, Singh, Niten, Woo, Russell, Hashmi, Zain G. , Brooke, Benjamin S. , Huang, Eunice Y. , Adelson, P. David , Sewell, Marisa , Woo, Russell

Mayo Clinic

Journal of the American College of Surgeons | March 12, 2026 | Volume: 243 | Issue: 2 | Pages: 443-449

10.1097/xcs.0000000000001922 | PMID 41817107 Get It

The rapid adoption of telemedicine has transformed healthcare delivery in the US, enhancing access and communication for surgical patients across wide geographic areas. However, a critical challenge persists: the need to define and standardize quality metrics specifically for telemedicine in surgery. Existing studies suggest that telemedicine can yield equivalent or improved outcomes compared with in-person visits. Nevertheless, literature remains limited in evaluating patient satisfaction, cost-effectiveness, and diagnostic accuracy. Through expert consensus within the American College of Surgeons Board of Governors Telehealth Pillar, we propose a structured framework for defining and implementing quality metrics for surgical telemedicine. This is based on the Donabedian model, addressing structure, process, and outcome, while also considering the distinct phases of surgical care: preoperative, intraoperative, and postoperative. This framework identifies unique domains of telemedicine in surgical care, emphasizing hospital and organizational structure, patient and provider readiness, and policy alignment. A comparative analysis with existing AHRQ and WHO frameworks highlights gaps in surgical applicability. Finally, we propose an implementation roadmap prioritizing immediate, feasible metrics while identifying areas for future validation. Collaboration among researchers, clinicians, and policymakers will be essential to establish these metrics and ensure that telemedicine delivers on its potential to improve surgical care delivery while addressing disparities in access and outcomes.